Translocator protein (18 kDa) (TSPO) ligands activate Nrf2 signaling and attenuate inflammatory responses and oxidative stress in human retinal pigment epithelial cells.
Actins
/ metabolism
Autophagy
Caspase 1
/ metabolism
Cell Line
Cytoskeleton
/ metabolism
Enzyme Activation
Gene Expression Regulation
Humans
Inflammation
/ genetics
Inflammation Mediators
/ metabolism
Ligands
Lipid Metabolism
Lipids
/ chemistry
NF-E2-Related Factor 2
/ metabolism
Oxidative Stress
/ genetics
Reactive Oxygen Species
/ metabolism
Receptors, GABA
/ metabolism
Retinal Pigment Epithelium
/ pathology
Signal Transduction
Stress, Physiological
Atrophic AMD
LLOMe
Microglia
NrF2 pathway
Retinal pigment epithelium
TSPO ligands
Journal
Biochemical and biophysical research communications
ISSN: 1090-2104
Titre abrégé: Biochem Biophys Res Commun
Pays: United States
ID NLM: 0372516
Informations de publication
Date de publication:
23 07 2020
23 07 2020
Historique:
received:
29
04
2020
accepted:
17
05
2020
pubmed:
3
6
2020
medline:
14
1
2021
entrez:
3
6
2020
Statut:
ppublish
Résumé
Degeneration of the retinal pigment epithelium (RPE) is a hallmark of atrophic age-related macular degeneration (AMD). Microglia mediated inflammatory responses and oxidative stress are critical pathophysiological processes in the onset and progression of RPE degeneration. Given the central role of the RPE, strategies to protect these cells from damage caused by oxidative stress and inflammation present a promising therapeutic approach to mitigate AMD. Ligands for the translocator protein (18 kDa) (TSPO) have been shown to confer protection against retinal inflammatory responses and neurodegeneration by acting primarily through retinal glia. However, despite RPE cells demonstrating strong TSPO expression, it remains unclear whether TSPO ligands could also inhibit inflammatory responses of RPE cells. Here, we investigated the influence of three different TSPO ligands XBD173, PK11195 and Ro5-4864 on inflammatory responses in human ARPE-19 cells triggered by supernatants from reactive human microglial cells and the lysosomal destabilizer, LLOMe. Our findings revealed that TSPO ligands significantly inhibited proinflammatory gene expression, inflammasome-mediated caspase-1 activation, lipid accumulation and intracellular ROS levels in stressed ARPE-19 cells. Notably, TSPO ligands induced activation of Nrf2 pathway and its downstream regulated genes in ARPE-19 cells, with Hmox-1 being the most strongly upregulated gene. Collectively, our study indicates that TSPO ligands can enhance the Nrf2 antioxidant pathway in RPE cells and protect them from cellular damage resulting from inflammation and oxidative stress.
Identifiants
pubmed: 32482385
pii: S0006-291X(20)31036-6
doi: 10.1016/j.bbrc.2020.05.114
pii:
doi:
Substances chimiques
Actins
0
Inflammation Mediators
0
Ligands
0
Lipids
0
NF-E2-Related Factor 2
0
Reactive Oxygen Species
0
Receptors, GABA
0
TSPO protein, human
0
Caspase 1
EC 3.4.22.36
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
261-268Informations de copyright
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.